WEST PHARMACEUTICAL SERVICES INC - COM (WST)

Historical Portfolio Holders from Q1 2014 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
67.6M
Holdings value Q3 2024
$20.2B
Value change Q3 2024
-$185M
Grand Portfolio weight change Q3 2024
0%
Number of holders
713
Number of buys Q3 2024
337
Number of sells Q3 2024
-364
Average buys Q3 2024 %
+0.002%
Average sells Q3 2024 %
-0.003%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 67.6M $20.2B -$185M $300.16 718
2024 Q2 68.3M $22.5B +$210M $329.39 765
2024 Q1 67.7M $26.7B -$378M $395.71 771
2023 Q4 68.6M $24.1B +$297M $352.12 767
2023 Q3 67.6M $25.4B -$129M $375.21 746
2023 Q2 68M $25.9B -$537M $382.47 719
2023 Q1 69.5M $24B +$336M $346.47 678
2022 Q4 69M $16.2B +$87.4M $235.35 622
2022 Q3 68.5M $16.9B -$424M $246.08 612
2022 Q2 68.2M $20.6B -$318M $302.37 638
2022 Q1 68.9M $28.2B +$11.8M $410.71 698
2021 Q4 68.8M $32.1B +$623M $469.01 715
2021 Q3 67.3M $28.4B -$755M $424.54 658
2021 Q2 69.1M $24.7B +$170M $359.10 631
2021 Q1 68.6M $19.2B +$626K $281.78 580
2020 Q4 68.7M $19.4B +$181M $283.31 579
2020 Q3 68M $18.7B -$208M $274.90 562
2020 Q2 68.7M $15.7B +$423M $227.17 514
2020 Q1 67.1M $10.2B -$57.9M $152.25 456
2019 Q4 67.5M $10.1B +$89.4M $150.33 436
2019 Q3 67.1M $9.51B -$48.1M $141.82 399
2019 Q2 67.5M $8.44B +$21.2M $125.15 366
2019 Q1 67.8M $7.47B -$148M $110.20 369
2018 Q4 69.3M $6.79B +$30.4M $98.03 347
2018 Q3 68.8M $8.49B +$105M $123.47 349
2018 Q2 69M $6.85B -$116M $99.29 319
2018 Q1 70.2M $6.2B +$38.5M $88.29 321
2017 Q4 69.8M $6.89B -$49.2M $98.67 334
2017 Q3 69.8M $6.72B +$237M $96.26 300
2017 Q2 67.2M $6.36B +$134M $94.52 308
2017 Q1 66.6M $5.44B +$388M $81.61 291
2016 Q4 66.2M $5.62B +$85.6M $84.83 281
2016 Q3 66.2M $4.93B +$102M $74.50 273
2016 Q2 65.3M $4.96B -$144M $75.88 281
2016 Q1 66.6M $4.62B +$75.1M $69.32 242
2015 Q4 67.1M $4.04B -$13.3M $60.22 244
2015 Q3 67.6M $3.66B +$15.4M $54.12 247
2015 Q2 67.5M $3.92B +$8.86M $58.08 217
2015 Q1 67.4M $4.05B +$107M $60.21 213
2014 Q4 65.8M $3.5B -$16.8M $53.24 224
2014 Q3 66.2M $2.96B +$85.9M $44.76 213
2014 Q2 64.5M $2.72B +$34M $42.18 220
2014 Q1 63.6M $2.8B +$29.8M $44.05 222